NCT07731724 Effects of Barre-Based Core Stability With and Without Tupler Technique on Core Strength, Inter Recti Distance, and Pelvic Floor Function Among Diastasis Recti Abdominis Patients
| NCT ID | NCT07731724 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lahore University of Biological and Applied Sciences |
| Condition | Diastasis Recti Abdominis (Postpartum) |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2026-05-01 with a primary completion date of 2026-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be a single blind, parallel group randomized controlled trial designed to evaluate the effectiveness of Barre-based core stability training with and without the Tupler Technique in postpartum women with Diastasis Recti Abdominis. A total of 58 eligible participants will be recruited from postpartum care units and randomly assigned in a 1:1 allocation ratio to either an experimental group receiving Barre-based core stability training combined with the Tupler Technique or a control group receiving Barre-based core stability training alone. Both interventions will be delivered under supervised conditions three times per week for 8 weeks, with each session lasting approximately 30-45 minutes. The Barre-based program focuses on controlled low impact movements aimed at improving deep core muscle activation, postural alignment, and neuromuscular coordination. The experimental group will additionally receive the Tupler Technique, which includes abdominal splinting, progressive core strengthening exercises, and neuromuscular re-education targeting approximation of the rectus abdominis muscles and improved abdominal wall function. Outcome measures include inter-recti distance, core strength, and pelvic floor function. Secondary outcomes include postural stability and functional performance. Assessments will be conducted at baseline, mid-intervention (week 4), post-intervention (week 8), and follow-up (week 12) by blinded outcome assessors to minimize bias. The purpose of this trial is to determine whether combining the Tupler Technique with Barre-based core stability training provides superior improvements in abdominal separation, core strength, pelvic floor function, and functional ability compared with Barre-based training alone in postpartum women.
Eligibility Criteria
Inclusion Criteria * Women aged 18-40 years * Postpartum period between 6-12 months * Diagnosed with stage I-II Diastasis Recti Abdominis * Presence of symptoms such as abdominal weakness or back pain * Ability to follow exercise instructions Exclusion Criteria * Stage III Diastasis Recti Abdominis * Severe hernias or significant pelvic floor dysfunction * Neurological, cardiovascular, or systemic conditions contraindicating exercise * History of abdominal surgery or trauma affecting the abdominal wall
Contact & Investigator
WHO
PRINCIPAL INVESTIGATOR
Lahore University of Biological and Applied Sciences
Frequently Asked Questions
Who can join the NCT07731724 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Diastasis Recti Abdominis (Postpartum). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07731724 currently recruiting?
Yes, NCT07731724 is actively recruiting participants. Contact the research team at hafsaliaquat39@gmail.com for enrollment information.
Where is the NCT07731724 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07731724 clinical trial?
NCT07731724 is sponsored by Lahore University of Biological and Applied Sciences. The principal investigator is WHO at Lahore University of Biological and Applied Sciences. The trial plans to enroll 58 participants.